Keyphrases
Nanoparticles
100%
Age-related Macular Degeneration
100%
Pathological Factors
100%
Humanin
100%
Drug Release
75%
Biocompatibility
50%
Apoptosis
50%
Chitosan Nanoparticles
50%
Drug Delivery System
25%
Therapeutic Potential
25%
Alzheimer's Disease
25%
Surface Charge
25%
Developing World
25%
Current Treatment
25%
Pharmacokinetics
25%
Causes of Blindness
25%
Disease Treatment
25%
Treatment Options
25%
Drug Nanoparticles
25%
Free Drug
25%
Free Protein
25%
Pharmacokinetic Properties
25%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
25%
VEGF Expression
25%
Cellular Toxicity
25%
VEGF Secretion
25%
Encapsulation Efficiency
25%
Hypoxic Cells
25%
Stable Surface
25%
ARPE-19 Cells
25%
Cytokine Receptor
25%
Retinal Apoptosis
25%
Release Capacity
25%
Property Protection
25%
Oxidative Protection
25%
IL-6 Cytokine
25%
Negative Side Effects
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Age Related Macular Degeneration
100%
Humanin
100%
Drug Release
75%
Vasculotropin
75%
Pharmacokinetics
50%
Chitosan Nanoparticle
50%
Drug Delivery System
25%
Biocompatibility
25%
Disease
25%
Alzheimer's Disease
25%
Side Effect
25%
Omeprazole
25%
Cytokine Receptor
25%
Neuroscience
Age-Related Macular Degeneration
100%
Humanin
100%
Vascular Endothelial Growth Factor
75%
In Vitro
50%
Pharmacokinetics
50%
Chitosan
50%
Treatment of Alzheimer's Disease
25%
Retinal Apoptosis
25%
Cytokine Receptor
25%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Chitosan
66%
Surface Charge
33%
Pharmacokinetics
33%
Secretion (Process)
33%
Interleukin-6
33%
Cytokine Receptor
33%
Pharmacokinetic Properties
33%